SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-23-260123
Filing Date
2023-10-23
Accepted
2023-10-20 21:23:23
Documents
6
Effectiveness Date
2023-10-23

Document Format Files

Seq Description Document Type Size
1 S-8 d535147ds8.htm S-8 64719
2 EX-5.1 d535147dex51.htm EX-5.1 9338
3 EX-23.1 d535147dex231.htm EX-23.1 1680
4 EX-23.2 d535147dex232.htm EX-23.2 1420
5 EX-FILING FEES d535147dexfilingfees.htm EX-FILING FEES 25414
6 GRAPHIC g535147dsp12.jpg GRAPHIC 3898
  Complete submission text file 0001193125-23-260123.txt   109215
Mailing Address 27 WEST 24TH STREET SUITE 702 NEW YORK NY 10010
Business Address 27 WEST 24TH STREET SUITE 702 NEW YORK NY 10010 646-481-9832
Tourmaline Bio, Inc. (Filer) CIK: 0001827506 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-275131 | Film No.: 231338350
SIC: 2836 Biological Products, (No Diagnostic Substances)